Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Medicine & Geriatrics, Hong Kong Clinical Trials

A listing of Medicine & Geriatrics, Hong Kong clinical trials actively recruiting patients volunteers.

RESULTS

Found (27) clinical trials

Lung-MAP S1400K: c-MET Positive

S1400K of Lung-MAP seeks to evaluate the overall response rate with ABBV-399 (Process II) in patients with c-MET positive SCCA. S1400K is a biomarker-driven study for patients with Stage IV or recurrent squamous cell lung cancer, who have c-MET positive squamous cell tumors.

Phase

0.53 miles

Learn More »

A Study of JNJ-63723283 a Programmed Cell Death Receptor-1 (PD-1) Inhibitor Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer

This study is of participants with mCRPC who have progressed after therapy with an androgen receptor (AR)-targeted agent and have not received chemotherapy. Participants must have confirmed prostate-specific antigen (PSA) progression per Prostate Cancer Clinical Trials Working Group (PCWG3) criteria. The primary hypothesis is that treatment with JNJ-63723283 and apalutamide ...

Phase

0.53 miles

Learn More »

Study of Topical SOR007 Ointment for Cutaneous Metastases

This is a Phase 1/2, open-label, dose-rising study evaluating the safety, tolerability and preliminary efficacy of three concentrations of SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment (0.15%, 1.0%, and 2.0%) applied to non-melanoma cutaneous metastases. A treatment area of 50 cm2 will be selected by the Investigator. Using a gloved hand, subjects ...

Phase

0.53 miles

Learn More »

Dual-Time Point (DTP) FDG PET CT for the Post-Treatment Assessment of Head and Neck Tumors Following Definitive Chemoradiation Therapy

The goal of this clinical research study is to compare the results of a dual time point (standard and delayed) FDG PET/CT of the head and neck before and after chemo-radiation therapy. This is an investigational study. The FDG PET/CT is delivered using FDA approved and commercially available methods. It ...

Phase N/A

0.53 miles

Learn More »

Ponatinib + Venetoclax for Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

There are 2 phases to this clinical research study: Phase 1 and Phase 2. The goal of Phase 1 is to find the highest tolerable dose of venetoclax that can be given in combination with ponatinib to patients with certain types of leukemia. The goal of Phase 2 is to ...

Phase

0.53 miles

Learn More »

Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement

Study eyes will be assigned randomly (1:1 ratio) to one of the following 2 treatment arms. Randomization of PDR subjects will be limited to 50% of each arm. Group 1- Subjects will be seen every month, 28 days (+ 7 days), for 52 weeks. All subjects will receive IAI at ...

Phase

0.53 miles

Learn More »

Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy

This protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate follow-up can be maintained for subjects who have received at least one dose of algenpantucel-L.

Phase N/A

0.53 miles

Learn More »

GEN1029 (HexaBody -DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors

The trial is an open-label, multi-center safety trial of GEN1029 (HexaBody-DR5/DR5). The trial consists of two parts a dose escalation part (phase 1, first-in-human (FIH) and an expansion part (phase 2a). The expansion part of the trial will be initiated once the Recommended Phase 2 Dose (RP2D) has been determined.

Phase

0.53 miles

Learn More »

Study of Stereotactic Body Radiation Therapy for Oligometastatic Renal Cell Carcinoma

Study Therapy: If participant is found to be eligible to take part in this study, participant will receive radiation therapy, surgery, and/or other local therapies. The study doctor will discuss with participant the dose and schedule of radiation that participant will receive, based on the disease site. Participant may ask ...

Phase N/A

0.53 miles

Learn More »

Watchful Living: A Lifestyle Intervention for Black Prostate Cancer Patients on Active Surveillance and Their Partners

Baseline Visit: If you agree to take part in this study, the following procedures will be performed at your baseline (first) visit: You will complete a computer-based questionnaire about your age, education, social status, health status, mood, diet, level of physical activity, and quality of life. The questionnaire should take ...

Phase N/A

0.53 miles

Learn More »